| |
Current regulatory requirements for APIs The adoption of a global regulatory framework for active pharmaceutical ingredients (APIs) can only be of benefit to the licensing authorities, the industry and - last but not least - the patient. Dr Chris Oldenhof, DSM/Gist-brocades (January 2000)
Keywords: peptides, fine chemicals, active pharmaceutical ingredients, contract manufacturing, chiral, chiral synthesis, , chiral technology, intermediates, enantiomers, bulk pharmaceuticals, chemical synthesis, galenic development, raw materials, biocatalysts, botanicals, biochemistry, chemical analysis, solid phase combinatorial synthesis, specialty chemicals, intermediate synthesis, peptide chemistry, DSM/Gist-brocades, active pharmaceutical ingredients, APIs
|
